Health systems are struggling with the tension between COVID-19’s immediate demands and the long-term struggle against tuberculosis—one of the deadliest infectious diseases.
Over 95% of cases are in developing countries, and pandemic-related care disruptions may well interrupt the goal of ending TB by 2030.
The fallout could be massive—half of untreated TB cases in HIV-negative people are fatal; for the HIV-positive, untreated TB is essentially a death sentence.
That bleak picture is pushing countries like Peru—which has the highest rate of drug-resistant TB in the Americas—to innovate. It’s expanding AI-driven diagnostics through mobile diagnostic units.